Levofloxacino Reiwa Healthcare

Levofloxacin, the active ingredient in Levofloxacino Reiwa Healthcare, is a fluoroquinolone antibiotic presented as a sterile solution for intravenous use. It treats a range of serious bacterial infections in adult patients, including pneumonia, urinary tract, intra‑abdominal and skin infections.

GNH USA supplies Levofloxacino Reiwa Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement agencies worldwide.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, abdominal and skin systems.

Community‑acquired pneumonia: achieves clinical cure and microbiological eradication in adults. Hospital‑acquired pneumonia: provides effective treatment of severe nosocomial lung infections. Complicated urinary tract infections: resolves infection and prevents recurrence. Complicated intra‑abdominal infections: aids in bacterial clearance after surgical source control. Skin and soft tissue infections: promotes healing by eliminating causative pathogens.

Levofloxacin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or vomiting - Diarrhea or loose stools - Headache - Dizziness or vertigo - Rash or mild skin irritation - Elevated liver enzymes

Serious or Rare Side Effects: - Tendon rupture or tendinitis - QT interval prolongation and cardiac arrhythmias - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile‑associated colitis - Peripheral neuropathy - Hepatic failure or severe liver injury

When prescribing Levofloxacino Reiwa Healthcare, clinicians should consider several precautionary measures to minimise risk.

Renal impairment: adjust dose based on renal function. History of tendon disorders: avoid use or monitor closely for tendon pain. QT prolongation risk: assess cardiac history and electrolyte status. Concomitant CNS‑active drugs: monitor for seizures or heightened stimulation. Pregnancy and lactation: use only if benefits outweigh potential risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Theophylline: levofloxacin can raise serum theophylline concentrations. - Cyclosporine: increased risk of nephrotoxicity. - Co‑administration with other fluoroquinolones: additive QT‑prolongation risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: heightened central nervous system stimulation. - Corticosteroids: increased likelihood of tendon rupture. - Diabetes medications: potential for dysglycemia. - Rifampin: may lower levofloxacin plasma levels. - Oral contraceptives: possible reduction in contraceptive effectiveness.